Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy
about
Clinical utility of serum biomarkers in Duchenne muscular dystrophyRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseMicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosisInvestigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular DystrophySelective release of muscle-specific, extracellular microRNAs during myogenic differentiationNovel long noncoding RNAs (lncRNAs) in myogenesis: a miR-31 overlapping lncRNA transcript controls myoblast differentiationPrevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptomsMega roles of microRNAs in regulation of skeletal muscle health and diseaseDysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia.Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.miRNA expression in control and FSHD fetal human muscle biopsiesAssessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serumMicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice.How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouseSerum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx MiceMulti-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapiesTNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular DystrophyComprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitationsAssociation of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery CentersIdentification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approachThe functional consequences of age-related changes in microRNA expression in skeletal muscle.RNAi2013: RNAi at OxfordMicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases.Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide TherapyExtracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnoverMicroRNA-206: a promising theranostic marker.Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urineMiRNA-199a-3p regulates C2C12 myoblast differentiation through IGF-1/AKT/mTOR signal pathway.Circulating Biomarkers for Duchenne Muscular Dystrophy.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.What do mouse models of muscular dystrophy tell us about the DAPC and its components?mRNA and microRNA transcriptomics analyses in a murine model of dystrophin loss and therapeutic restoration.Detection and quantification of extracellular microRNAs in murine biofluids.
P2860
Q26751261-0128BD19-197B-49FF-BC61-B53A95861D72Q26795757-B9C3989D-2C47-4EAD-ACB9-5BD57035B534Q27321524-1D443ABB-C6B4-4BDB-B20A-3CCC9827C370Q28598287-B962CBD1-FF2D-4645-836D-714F44CD63A5Q28817525-7C21AA52-B76F-46B0-BB79-54C9DD1E9786Q29048207-779123C4-E0CE-411A-B15B-28C489BF96CAQ30626615-090E8234-D196-4395-913E-634BF58EFAB7Q33685967-EB2E2757-B128-46ED-8D5A-DE6546057E10Q33810713-F6805CF1-7F43-4C4A-AC7C-F15407428CB5Q33916185-41A29F65-F91C-4F02-96C6-CE693CEC8223Q35055089-06202684-0B57-489D-8260-3313040AC381Q35099175-C8B14EC0-695F-47A7-A692-8222130D2A81Q35106915-6FC80030-3B1B-4804-9DCB-9E5750F7C534Q35569587-802CC4C6-39C9-4776-B97D-26C6D18D2C9CQ35821127-F19930E6-067B-4E4D-9059-2C4545B51713Q35924068-606AB6AD-3F7D-4D37-B917-BA3CC7A623DFQ36015171-7C001EA1-594A-4095-B372-3EE4DE6DAD3CQ36139893-24A9E741-5871-4F62-9724-E56560FF9C12Q36224892-7F108381-E182-4986-8DA1-8E570B1A65AFQ36252005-0917D6A4-3F4B-4425-ADD0-E6E981E764ECQ36305436-DCA8A919-6A33-418D-9D48-C63682A833F4Q36584640-8769D688-9A5B-4E74-BA54-20DCDEF37C7EQ36590389-132C3475-DE9A-47A1-8BBE-BF94772ECB60Q36693002-F119451C-956C-4512-AB5F-95DDCF68B2B1Q36786213-1AD118B5-32A6-4AF4-B38E-49957265F586Q36875975-892E1A71-FCBE-43F6-AE8A-201555457301Q36958102-A7C9DCB0-97A4-47CE-995F-49E336DAB527Q37029413-A68635C4-120D-4047-9408-A6B1A57AD911Q37090136-0A7D32CF-8B36-4D86-9E2B-764E01584067Q37183460-71042B8C-6726-42FD-AD7D-469DA8BFF526Q37238936-84AB780F-C473-4EC8-948E-FA87151EC5E2Q37271171-A44C8F5E-83C2-495B-AD81-85A65CC14065Q37511094-AC3004A9-95DD-44CF-88E9-A0ACF059FC35Q37518858-2AE8FBA0-4B3E-457D-8E2D-10CE0BAA6ECFQ37535443-E93ABDD7-F67E-4A11-91F0-DC3B6FC1109EQ37610530-84344D84-58BC-4091-9756-1C9C5C9FFA28Q38115148-E351206F-DA32-4783-9F87-0AF8499B54F1Q38255744-162E49DA-399B-477D-A653-4EC5DBB83FAEQ38783823-AF94419D-CD4B-43D3-ACF8-D785197BBE93Q38895005-80F9DA72-A212-4DED-8EF1-053D10C7FE7E
P2860
Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression analysis in multipl ...... with implications for therapy
@ast
Expression analysis in multipl ...... with implications for therapy
@en
type
label
Expression analysis in multipl ...... with implications for therapy
@ast
Expression analysis in multipl ...... with implications for therapy
@en
prefLabel
Expression analysis in multipl ...... with implications for therapy
@ast
Expression analysis in multipl ...... with implications for therapy
@en
P2093
P2860
P356
P1476
Expression analysis in multipl ...... with implications for therapy
@en
P2093
C I Edvard Smith
Caroline Godfrey
Corinne Betts
Graham McClorey
K Emelie M Blomberg
Matthew J A Wood
Michael J Gait
Samir El Andaloussi
Thibault Coursindel
Thomas C Roberts
P2860
P356
10.1038/MTNA.2012.26
P577
2012-08-14T00:00:00Z